Clinical Trial Results Show Synergy between NuSirt Technology and Metformin in Patients with Type 2 Diabetes read more 01/26/16
Clearside Biomedical, Inc. Completes Enrollment in Phase 2 Clinical Trial of CLS-TA for the Treatment of Retinal Vein Occlusion Using Suprachoroidal Space (SCS™) Drug Administration read more 12/14/15
NuSirt Biopharma Receives FDA Fast Track Designation for Non-Alcoholic Fatty Liver Disease Treatment read more 12/10/15
Clearside Biomedical, Inc. Initiates Phase 2 Clinical Trial For the Treatment of Macular Edema Associated With Non-Infectious Uveitis read more 01/15/15
NuSirt Biopharma Technology Presented at American Diabetes Association Scientific Sessions read more 07/07/14
